Kümmel, Sherko, et al. “Primary Systemic Chemotherapy With Sequential, Dose-Dense Epirubicin and Docetaxel for Inoperable, Locally Advanced Inflammatory Breast Cancer: A Phase II Study”. Acta Oncologica, vol. 44, no. 3, May 2005, pp. 248-54, doi:10.1080/02841860510029725.